Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/22731
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVillesen, H.en
dc.contributor.authorFoster, D.en
dc.contributor.authorUpton, R.en
dc.contributor.authorSomogyi, A.en
dc.contributor.authorMartinez, A.en
dc.contributor.authorGrant, C.en
dc.date.issued2006en
dc.identifier.citationJournal of Pharmaceutical Sciences, 2006; 95(8):1666-1676en
dc.identifier.issn0022-3549en
dc.identifier.issn1520-6017en
dc.identifier.urihttp://hdl.handle.net/2440/22731-
dc.descriptionPublished in Journal of Pharmaceutical Sciences, 2006; 95 (8):1666-1676 at www.interscience.wiley.comen
dc.description.abstractOxycodone is an opioid analgesic that is administered orally or parenterally. The time-course of opioid action is a function of the systemic kinetics of the opioid, and the rate and extent of its entry into the brain and central nervous system. The latter is incompletely understood for oxycodone. Therefore, the cerebral kinetics of oxycodone was quantified using a conscious chronically instrumented sheep preparation. Five sheep were administered oxycodone as intravenous infusions (30 mg over 4 min). Using hybrid physiologically based kinetic models, cerebral kinetics was estimated from arterio-sagittal sinus concentration gradients and cerebral blood flow (CBF). A two-compartment membrane-limited model best described the data. The volume of the first brain compartment was 35.4 mL with a half-life of equilibrium of 0.6 min. The brain:blood equilibration of oxycodone was relatively slow (half-life of 7.2 min), with a large deep cerebral distribution volume (222.8 mL) for the second compartment and a moderate membrane permeability of 54.8 mL/min, which exceeded the nominal CBF (40 mL/min). Drug retention in the brain was 1.3% after 45 min. In conclusion, pharmacokinetic modelling of oxycodone showed a delayed equilibration between brain and blood of a nature that would be affected by changes in both CBF and blood brain barrier permeability.en
dc.description.statementofresponsibilityHanne H. Villesen, David J.R. Foster, Richard N. Upton, Andrew A. Somogyi, Allison Martinez, Cliff Granten
dc.language.isoenen
dc.publisherJohn Wiley & Sons Incen
dc.subjectOxycodone; pharmacokinetics; distribution; blood brain barrier; blood flow; physiological model; sheepen
dc.titleCerebral kinetics of oxycodone in conscious sheepen
dc.typeJournal articleen
dc.identifier.rmid0020061032en
dc.identifier.doi10.1002/jps.20632en
dc.identifier.pubid52550-
pubs.library.collectionAnaesthesia and Intensive Care publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Anaesthesia and Intensive Care publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.